Orion completes acquisition of LegoChem Biosciences

COMPANY / Reporter Kim SangJin / 2024-04-01 03:57:19

(Photo = Yonhap news)

 

[Alpha Biz=(Chicago) Reporter Paul Lee] Orion said it has become the largest shareholder after paying 548.5 billion won in stock prices to acquire a 25.73% stake in LegoChem Biosciences.

Orion participated in LegoChem Biosciences's third-party paid-in capital increase and was allocated 7,963,283 shares for 59,000 won. It purchased 1.4 million old shares at a base price of 56,186 won from its founder Kim Yong-joo and CEO Park Se-jin to secure a total of 9,363,283 shares.

It plans to develop new drugs through its affiliate LegoChem Biosciences and complete its business portfolio for the group's sustainable growth.

 

 

Alphabiz Reporter Kim SangJin(hoondork1977@alphabiz.co.kr)

어플

주요기사

Kolmar Korea Certified as Year’s First ‘Reshoring’ Company; To Invest 100 Billion KRW in Smart Factory Expansion
Court Dismisses Additional Lawsuits by Shareholders Over "Invossa" Controversy, Ruling in Favor of Kolon
Nvidia Delays China H200 Chip Exports Amid Ongoing Talks With U.S. Government
Naver Issues Formal Apology Over Exposure of Celebrities’ and Politicians’ Past "Ji-sik-iN" Posts
CJ Logistics Designated as Unfaithful Disclosure Corporation Over Delayed Notice of $2.7B Libyan Counterclaim
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

SNS